Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease

ConclusionsIn the patients with NAFLD, SMI was decreased, even in the early stages of NAFLD. Therapeutic strategies for NAFLD require a reduction in body fat mass and the maintenance of skeletal muscle is also needed.

http://link.springer.com/10.1007/s00535-018-1485-8

Source: Journal of Gastroenterology - June 14, 2018 Category: Gastroenterology Source Type: research